PD Dr. Manuela Krumbholz



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers (2023) Hofmann G, Zierk J, Sobik B, Wotschofsky Z, Sembill S, Krumbholz M, Metzler M, Karow A Journal article Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia (2023) Volz C, Zerjatke T, Gottschalk A, Semper S, Suttorp M, Glauche I, Krumbholz M, Metzler M Journal article Synergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment (2023) Häselbarth L, Gamali S, Saul D, Krumbholz M, Böttcher-Loschinski R, Böttcher M, Zou D, et al. Journal article Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations (2023) Sembill S, Ampatzidou M, Chaudhury S, Dworzak M, Kalwak K, Karow A, Kiani A, et al. Journal article, Review article Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib (2023) Häselbarth L, Karow A, Mentz K, Böttcher M, Roche-Lancaster O, Krumbholz M, Jitschin R, et al. Journal article Patient-reported health-related quality of life (HRQOL) following allogeneic stem cell transplantation (SCT) performed early after diagnosis of pediatric chronic myeloid leukemia (CML) (2022) Schleicher O, Horndasch A, Krumbholz M, Sembill S, Karow A, Bremensdorfer C, Grabow D, et al. Conference contribution Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia (2022) Schleicher O, Horndasch A, Krumbholz M, Sembill S, Bremensdorfer C, Grabow D, Erdmann F, et al. Journal article Targeting metabolism effectively complements tyrosine kinase inhibitor treatment of chronic myeloid leukemia (2022) Häselbarth L, Saul D, Krumbholz M, Mougiakaos D, Metzler M, Karow A Conference contribution CtDNA release mechanisms in a therapeutic Ewing Sarcoma mouse model (2022) Eiblwieser J, Krumbholz M, Semper S, Frey B, Nagel L, Bäuerle T, Metzler M Conference contribution The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase (2022) Karow A, Göhring G, Sembill S, Lutterloh F, Neuhaus F, Callies S, Schirmer E, et al. Journal article
1 2 3 4